Skip to main content

Table 3 Numbers of study subjects receiving potentially inappropriate medications for treatment of GAD*

From: Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder

Medication

Potentially Inappropriate

Possibly Appropriate

Total

Benzodiazepines

   

   Short-acting

   

Alprazolam1

0 (0.0)

29 (3.0)

29 (3.0)

Lorazepam2

50 (5.1)

21 (2.2)

71 (7.3)

Lormetazepam

14 (1.4)

0 (0.0)

14 (1.4)

Oxazepam3

0 (0.0)

88 (9.0)

88 (9.0)

Temazepam4

8 (0.8)

0 (0.0)

8 (0.8)

Tetrazepam

0 (0.0)

29 (3.0)

29 (3.0)

Triazolam5

0 (0.0)

1 (0.1)

1 (0.1)

Zolpidem6

32 (3.3)

3 (0.3)

34 (3.5)

Any of above

97 (9.9)

162 (16.6)

242 (24.8)

   Long-acting**

   

Chlordiazepoxide

6 (0.6)

---

6 (0.6)

Chlorazepate

11 (1.1)

---

11 (1.1)

Clobazam

2 (0.2)

---

2 (0.2)

Clonazepam

3 (0.3)

---

3 (0.3)

Diazepam

91 (9.3)

---

91 (9.3)

Flunitrazepam

7 (0.7)

---

7 (0.7)

Flurazepam

6 (0.6)

---

6 (0.6)

Halazepam

0 (0.0)

---

0 (0.0)

Medazepam

5 (0.5)

---

5 (0.5)

Nordazepam

2 (0.2)

---

2 (0.2)

Prezepam

0 (0.0)

---

0 (0.0)

Bromazepam

93 (9.5)

---

93 (9.5)

Nitrazepam

14 (1.4)

---

14 (1.4)

Midazolam

0 (0.0)

---

0 (0.0)

Any of above

225 (23.1)

---

225 (23.1)

   Any of above

298 (30.6)

162 (16.6)

426 (43.7)

Tricyclic antidepressants

   

   Amitriptyline

52 (5.3)

---

52 (5.3)

   Amitriptylinoxide

0 (0.0)

3 (0.3)

3 (0.3)

   Clomipramine

0 (0.0)

4 (0.4)

4 (0.4)

   Dibenzepin

0 (0.0)

3 (0.3)

3 (0.3)

   Desipramine

0 (0.0)

0 (0.0)

0 (0.0)

   Doxepin

70 (7.2)

---

70 (7.2)

   Imipramine

0 (0.0)

0 (0.0)

0 (0.0)

   Maprotiline

0 (0.0)

4 (0.4)

4 (0.4)

   Nortriptyline

0 (0.0)

0 (0.0)

0 (0.0)

   Opipramol

0 (0.0)

105 (10.8)

105 (10.8)

   Trimipramine

0 (0.0)

29 (3.0)

29 (3.0)

   Any of above

119 (12.2)

142 (14.6)

250 (25.6)

Selective serotonin reuptake inhibitors

   

   Escitalopram

0 (0.0)

7 (0.7)

7 (0.7)

   Citalopram

0 (0.0)

40 (4.1)

40 (4.1)

   Fluoxetine

11 (1.1)

0 (0.0)

11 (1.1)

   Fluvoxamine

0 (0.0)

3 (0.3)

3 (0.3)

   Paroxetine

0 (0.0)

16 (1.6)

16 (1.6)

   Sertraline

0 (0.0)

13 (1.3)

13 (1.3)

   Any of above

11 (1.1)

77 (7.9)

86 (8.8)

Venlafaxine

0 (0.0)

9 (0.9)

9 (0.9)

Hydroxyzine

4 (0.4)

---

4 (0.4)

Buspirone

0 (0.0)

5 (0.5)

5 (0.5)

Pregabalin

0 (0.0)

0 (0.0)

0 (0.0)

Trifluoperazine

0 (0.0)

0 (0.0)

0 (0.0)

Any of above

392 (40.2)

345 (35.4)

607 (62.3)

  1. *All values are number of patients (%); dose calculated using all values found in database
  2. **Any use of long-acting benzodiazepines deemed potentially inappropriate
  3. 1Dose >2 mg/d deemed potentially inappropriate
  4. 2Dose >3 mg/d deemed potentially inappropriate
  5. 3Dose >60 mg/d deemed potentially inappropriate
  6. 4Dose >15 mg/d deemed potentially inappropriate
  7. 5Dose > 0.25 mg/d deemed potentially inappropriate
  8. 6Dose >5 mg/d deemed potentially inappropriate
  9. GAD: Generalized anxiety disorder